INTRAOCULAR LENS REFERENCE PRODUCT DEVELOPMENT PROTOCOL REQUIRES ONE YEAR STUDY FOR ALL POSTERIOR CHAMBER IOLS; PDP TEMPLATE ENDORSED BY FDA ADVISORY PANEL
This article was originally published in The Gray Sheet
Executive Summary
FDA's generic product development protocol for intraocular lenses would require all posterior chamber IOLs to be studied for at least one year, the document states.